A business in context
BIIB research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-09 | HAWKINS WILLIAM A | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | SHERWIN STEPHEN A | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | Rowinsky Eric K | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | Mantas Jesus B | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | LANGER SUSAN | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | Patolawala Monish D | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | Pangalos Menelas N | M · Exercise / conversion | Common Stock | 2370.0 | 0.0 |
| 2026-06-09 | Pangalos Menelas N | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | Pangalos Menelas N | M · Exercise / conversion | Restricted Stock Unit | 2370.0 | 0.0 |
| 2026-06-09 | Minor Lloyd | A · Grant / award | Common Stock | 1505.0 | 0.0 |
| 2026-06-09 | Freire Maria C | A · Grant / award | Common Stock | 2005.0 | 0.0 |
| 2026-05-01 | Keeney Adam | M · Exercise / conversion | Common Stock | 939.0 | 0.0 |
| 2026-05-01 | Keeney Adam | F · Tax / exercise payment | Common Stock | 455.0 | 187.06 |
| 2026-05-01 | Keeney Adam | M · Exercise / conversion | Restricted Stock Unit | 939.0 | 0.0 |
| 2026-04-01 | Godbout Sean | F · Tax / exercise payment | Common Stock | 54.0 | 183.78 |
| 2026-04-01 | Godbout Sean | M · Exercise / conversion | Common Stock | 181.0 | 0.0 |
| 2026-04-01 | Godbout Sean | M · Exercise / conversion | Restricted Stock Unit | 181.0 | 0.0 |
Identity & relationships
SEC issuer · 0000875045BIOGEN INC.
BiogenBiogen (Germany)Biogen (Belgium)Biogen (Switzerland)
- Legal Entity Identifier
- W8J5WZB5IY3K0NDQT671
- GLEIF legal name
- BIOGEN INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-01-21T05:42:45Z
Search names and former names
View Wikidata identity and references ↗
- Biogen · subsidiary · wikidata
- BIIB · alias · wikidata
- Biogen Idec · alias · wikidata
- Biogen (Germany) · subsidiary · wikidata
- Biogen (Belgium) · subsidiary · wikidata
- Biogen (Switzerland) · subsidiary · wikidata
- BIOGEN IDEC INC. · former SEC name · 2007-01-17 to 2015-03-20
- BIOGEN IDEC INC · former SEC name · 2003-11-12 to 2007-04-25
- IDEC PHARMACEUTICALS CORP / DE · former SEC name · 1997-10-01 to 2003-11-12
- IDEC PHARMACEUTICALS CORP / CA · former SEC name · 1996-07-10 to 1997-02-14
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $9.68B | $10.30B |
| 2023-12-31 | $9.84B | $10.78B |
| 2022-12-31 | $10.17B | $11.61B |
| 2021-12-31 | $10.98B | $13.53B |
| 2020-12-31 | $13.44B | $17.35B |
| 2019-12-31 | $14.38B | $18.78B |
| 2018-12-31 | $13.45B | $17.89B |
| 2017-12-31 | $12.27B | $16.72B |